Evidence map›Paper›PMID 34956683›Full record

ArticleCase reports in ophthalmological medicine2021

Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis.

Michael J Schatz, Carl S Wilkins, Oscar Otero-Marquez, Toco Y P Chui, Richard B Rosen, Meenakashi Gupta

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in ophthalmological medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael J SchatzThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0002-6181-525X
Carl S WilkinsThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0002-5289-9586
Oscar Otero-MarquezThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0003-1591-9952
Toco Y P ChuiThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0003-2060-3848
Richard B RosenThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0001-9643-3510
Meenakashi GuptaThe New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA.ORCID https://orcid.org/0000-0001-9255-5588
New York Eye and Ear Infirmary · US

Funding

Characterization of vascular responses to intravitreal anti-VEGF injections in diabetic retinopathyR01EY027301 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Yuen Ping Toco Chui · 2017 to 2026
$4.0M
NEI NIH HHS R01 EY027301
6 · The paper itself

Abstract

While plasmapheresis is well known to significantly improve both retinal findings and systemic manifestations associated with Waldenstrom macroglobulinemia, few reports exist documenting changes in optical coherence tomography angiography (OCT-A). The authors present a case of a patient with Waldenstrom macroglobulinemia who had resolution of white-centered peripheral retinal lesions and parafoveal outer nuclear layer hyperreflective material following plasmapheresis. Applying image analysis software to before and after OCT-A images, the authors were able to show an objective decrease in retinal capillary and large vessel density following plasmapheresis. This technique can be used to guide treatment and surveillance for patients with hyperviscosity-related retinopathy.

Identifiers

PMID34956683
PMCPMC8695004
OpenAlexW4200182339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.